Treatment with rapalogs has been shown to improve clinical outcomes and cause tumor regression in TSC patients with astrocytomas or sporadic LAM, again suggesting a dependence on mTOR signaling for tumor growth [60,61,62]. This evidence concerns the gene MTOR and neoplasm.